Abstract
BackgroundProbody® therapeutics are antibody prodrugs that are activated in the tumor microenvironment by tumor-associated proteases, thereby restricting the activity to the tumor microenvironment and minimizing ‘off-tumor’ toxicity. We report dose-escalation...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have